Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
MRK stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
Merck & Company, Inc. stock logo

Merck & Company, Inc.

MRK·NYSE

Last updated as of 2026-02-10 05:12 EST. Stock price information is sourced from TradingView and reflects real-time market prices.

Insights
Calculator
News

MRK stock price change

On the last trading day, MRK stock closed at 118.73 USD, with a price change of -2.62% for the day.
Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more

MRK key data

Previous close118.73 USD
Market cap294.69B USD
Volume3.69M
P/E ratio16.32
Dividend yield (TTM)2.69%
Dividend amount0.85 USD
Last ex-dividend dateDec 15, 2025
Last payment dateJan 08, 2026
EPS diluted (TTM)7.28 USD
Net income (FY)17.12B USD
Revenue (FY)63.97B USD
Next report dateFeb 3, 2026
EPS estimate2.010 USD
Revenue estimate16.20B USD
Shares float2.48B
Beta (1Y)0.53
Tokenized stocks

Have you heard of tokenized stocks?

A new way to trade stocks — anytime, anywhere, 24/7.

Learn more

Merck & Company, Inc. overview

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Sector
Health technology
Industry
Pharmaceuticals: Major
CEO
Robert M. Davis
Headquarters
Rahway
Website
merck.com
Founded
1891
Employees (FY)
75K
Change (1Y)
+3K +4.17%
Revenue / Employee (1Y)
852.97K USD
Net income / Employee (1Y)
228.23K USD

MRK Pulse

Daily updates on MRK stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• MRK Stock Price 24h change: -3.81%. From 121.93 USD to 117.28 USD. The drop was primarily driven by a "soft" 2026 financial guidance that fell below analyst expectations, despite a solid Q4 2025 earnings beat.
• From a technical perspective, the stock is showing a "bullish trend with near-term volatility": while MRK remains in a long-term uptrend and recently hit 52-week highs near $122, it is currently undergoing a technical correction to find support around the $115-$117 level following the guidance-led sell-off.
• Merck issued 2026 revenue guidance of $65.5B–$67B and adjusted EPS of $5.00–$5.15 on Feb 3, both slightly lower than consensus due to upcoming patent cliffs and acquisition-related charges.
• Health Canada approved Merck’s RSV monoclonal antibody, ENFLONSIA, for infants on Feb 9, providing a positive pipeline milestone to offset cautious financial outlooks.
• Multiple Merck top executives, including CEO Robert Davis and CFO Caroline Litchfield, executed significant stock sales totaling over 200,000 shares in early February following the recent price surge.
• GSK issued a measured 2026 outlook on Feb 9, projecting 3-5% sales growth as it prepares for HIV patent expirations and adapts to new U.S. drug pricing regulations.
• Global pharmaceutical companies are facing structural shifts as Swiss healthcare providers and international markets react to U.S.-driven drug pricing reforms, leading to some high-cost cancer drugs being withdrawn from smaller markets like Switzerland.
See more
about 18h ago
• MRK Stock Price 24h change: +1.82%. From 119.75 USD to 121.93 USD. The rise was driven by a stable Q4 2025 earnings report and strong performance from blockbuster drug Keytruda, despite a lower-than-expected 2026 outlook.
• From a technical perspective, the stock is in a "Strong Bullish" trend. The price is currently trading above its 8-day (114.34), 20-day (111.34), and 50-day (106.46) moving averages. Indicators like the RSI (62.38) and MACD suggest continued upward momentum, though some short-term oscillators indicate it is nearing overbought territory.
• Merck reported Q4 2025 revenue of $16.4 billion, beating expectations, with Keytruda sales reaching $8.4 billion, a 7% year-over-year increase.
• The company provided a cautious 2026 revenue guidance of $65.5–$67.0 billion, citing concerns over upcoming patent expirations for Keytruda in 2028 and declining Gardasil vaccine sales.
• Merck finalized several key clinical trial initiations in early February, including the Phase 3 KANDLELIT-007 trial for a new KRAS G12C inhibitor in combination with Keytruda.
• The U.S. FDA approved AbbVie’s EMBLAVEO on February 7, 2025, the first monobactam/β-lactamase inhibitor combo for complicated intra-abdominal infections, intensifying competition in the anti-infective space.
• New U.S. trade policies including specific pharmaceutical industry tariffs and a 10% baseline import tax took effect in early February 2025, raising concerns about inflationary pressures on drug ingredients and manufacturing costs.
See more
about 1D ago

MRK stock price forecast

According to technical indicators for MRK stock, the price is likely to fluctuate within the range of 125.69–137.03 USD over the next week. Market analysts predict that the price of MRK stock will likely fluctuate within the range of 115.28–161.66 USD over the next months.

Based on 1-year price forecasts from 70 analysts, the highest estimate is 242.85 USD, while the lowest estimate is 120.62 USD.

For more information, please see the MRK stock price forecast Stock Price Forecast page.

Latest MRK stock news

Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push

101 finance2026-01-30 16:12:28

What’s Ahead in the Markets This Week: January Employment Data; Earnings Releases from Alphabet, Amazon, AMD, Disney, and Palantir

101 finance2026-02-01 11:06:48

January employment report, Alphabet and Amazon financial results, further impact from Warsh: Key events to follow this week

101 finance2026-02-01 12:51:28

Commodity Price Fluctuations, Corporate Profits, and Other Important Factors to Monitor

101 finance2026-02-01 21:09:27

Merck (MRK) Fourth Quarter Earnings Preview: Key Points to Watch

101 finance2026-02-02 03:18:30

Merck forecasts 2026 sales below estimates on patent losses

101 finance2026-02-03 11:39:32

Merck: Fourth Quarter Earnings Overview

101 finance2026-02-03 11:51:35

Merck (NYSE:MRK) Reports Higher-Than-Expected Sales for Q4 2025

101 finance2026-02-03 12:54:30

Merck's quarterly results exceed expectations, but conservative 2026 guidance issued due to generic drug competition

新浪财经2026-02-03 13:26:14

Merck and Pfizer underperform the overall market following the announcement of their results

101 finance2026-02-03 13:30:13

Pre-market: Nasdaq futures up 0.45%, Palantir up nearly 12%

新浪财经2026-02-03 13:45:44

US Stocks Move | Merck rises about 4.5% to hit a new high in over a year, with Q4 sales and adjusted EPS exceeding expectations

格隆汇2026-02-03 15:07:00

Earnings Update: Merck, PepsiCo, and Eaton Release Q4 Results

币界网2026-02-03 17:47:33

Bristol-Myers Squibb Earnings: Key Points to Watch for BMY

101 finance2026-02-04 03:21:37

Merck veteran Perlmutter-led Eikon Therapeutics valued at $860 million in Nasdaq debut

101 finance2026-02-05 18:30:11

With just a Bitget account, you can trade stocks and cryptocurrencies at the same time.

Join now!

FAQ

What is the stock price of Merck & Company, Inc.?

MRK is currently priced at 118.73 USD — its price has changed by -2.62% over the past 24 hours. You can track the stock price performance of Merck & Company, Inc. more closely on the price chart at the top of this page.

What is the stock ticker of Merck & Company, Inc.?

Depending on the exchange, the stock ticker may vary. For instance, on NYSE, Merck & Company, Inc. is traded under the ticker MRK.

What is the stock forecast of MRK?

We've gathered analysts' opinions on Merck & Company, Inc.'s future price. According to their forecasts, MRK has a maximum estimate of 1187.30 USD and a minimum estimate of 237.46 USD.

What is the market cap of Merck & Company, Inc.?

Merck & Company, Inc. has a market capitalization of 294.69B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official Fee overview or Announcement Center page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
MRK